Literature DB >> 24827869

The diffusion of performance and image-enhancing drugs (PIEDs) on the internet: the abuse of the cognitive enhancer piracetam.

Ornella Corazza1, Francesco Saverio Bersani, Roberto Brunoro, Giuseppe Valeriani, Giovanni Martinotti, Fabrizio Schifano.   

Abstract

INTRODUCTION: Performance and image-enhancing drugs (PIEDs), also known as "lifestyle drugs," are increasingly sold on the Internet to enhance cognitive as well as sexual, muscular, attentive, and other natural capacities. Our analysis focuses on the misuse of the cognitive enhancer piracetam.
METHODS: A literature review was carried out in PsychInfo and Pubmed database. Considering the absence of peer-reviewed data, review of additional sources of unstructured information from the Internet was carried out between February 2012 and July 2013. Additional searches were conducted using the Global Public Health Intelligence Network (GPHIN), a secure Internet-based early warning system developed by Health Canada and the World Health Organization (WHO), which monitors media reports in six languages, Arabic, Chinese, English, French, Russian, and Spanish.
RESULTS: Piracetam is sold via illicit online pharmacies with no need of prescription at low prices. Buyers, mainly healthy individuals, purchase the product to enhance study- and work-related performances as well as for recreational purposes. Its nonmedical use is often associated with the occurrence of side effects such as hallucinations, psychomotor agitation, dysphoria, tiredness, dizziness, memory loss, headache, and severe diarrhoea; moreover, several users declared to have neither felt any cognitive improvement nor psychedelic effects.
CONCLUSIONS: This is a new and fast-growing trend of abuse that needs to be extensively monitored and studied also by using near real-time and unstructured sources of information such as Internet news and online reports in order to acquire rapid knowledge and understanding. Products sold online might be counterfeits and this enhances related health risks.

Entities:  

Keywords:  addiction; cognitive enhancer; drug abuse; online pharmacies; performance and image-enhancing drugs; piracetam

Mesh:

Substances:

Year:  2014        PMID: 24827869     DOI: 10.3109/10826084.2014.912232

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  18 in total

1.  Novel psychoactive substances of interest for psychiatry.

Authors:  Fabrizio Schifano; Laura Orsolini; G Duccio Papanti; John M Corkery
Journal:  World Psychiatry       Date:  2015-02       Impact factor: 49.548

Review 2.  Digital danger: a review of the global public health, patient safety and cybersecurity threats posed by illicit online pharmacies.

Authors:  Tim K Mackey; Gaurvika Nayyar
Journal:  Br Med Bull       Date:  2016-05-05       Impact factor: 4.291

Review 3.  Psychoactive drugs: occurrence in aquatic environment, analytical methods, and ecotoxicity-a review.

Authors:  Deivisson Lopes Cunha; Frederico Goytacazes de Araujo; Marcia Marques
Journal:  Environ Sci Pollut Res Int       Date:  2017-09-23       Impact factor: 4.223

Review 4.  Benefits and Harms of 'Smart Drugs' (Nootropics) in Healthy Individuals.

Authors:  Fabrizio Schifano; Valeria Catalani; Safia Sharif; Flavia Napoletano; John Martin Corkery; Davide Arillotta; Suzanne Fergus; Alessandro Vento; Amira Guirguis
Journal:  Drugs       Date:  2022-04-02       Impact factor: 9.546

5.  When an obscurity becomes trend: social-media descriptions of tianeptine use and associated atypical drug use.

Authors:  Kirsten E Smith; Jeffery M Rogers; Justin C Strickland; David H Epstein
Journal:  Am J Drug Alcohol Abuse       Date:  2021-04-28       Impact factor: 3.912

6.  Information sought, information shared: exploring performance and image enhancing drug user-facilitated harm reduction information in online forums.

Authors:  Boden Tighe; Matthew Dunn; Fiona H McKay; Timothy Piatkowski
Journal:  Harm Reduct J       Date:  2017-07-21

7.  Liver proteome alterations in psychologically distressed rats and a nootropic drug.

Authors:  Raquel González-Fernández; Mariana Grigoruţă; Sarahi Chávez-Martínez; Eliel Ruiz-May; José Miguel Elizalde-Contreras; José Valero-Galván; Alejandro Martínez-Martínez
Journal:  PeerJ       Date:  2021-05-19       Impact factor: 2.984

Review 8.  Adverse Psychiatric Effects Associated with Herbal Weight-Loss Products.

Authors:  F Saverio Bersani; Marialuce Coviello; Claudio Imperatori; Marta Francesconi; Christina M Hough; Giuseppe Valeriani; Gianfranco De Stefano; Flaminia Bolzan Mariotti Posocco; Rita Santacroce; Amedeo Minichino; Ornella Corazza
Journal:  Biomed Res Int       Date:  2015-09-17       Impact factor: 3.411

Review 9.  25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug.

Authors:  Francesco Saverio Bersani; Ornella Corazza; Gabriella Albano; Giuseppe Valeriani; Rita Santacroce; Flaminia Bolzan Mariotti Posocco; Eduardo Cinosi; Pierluigi Simonato; Giovanni Martinotti; Giuseppe Bersani; Fabrizio Schifano
Journal:  Biomed Res Int       Date:  2014-07-03       Impact factor: 3.411

Review 10.  Following "the Roots" of Kratom (Mitragyna speciosa): The Evolution of an Enhancer from a Traditional Use to Increase Work and Productivity in Southeast Asia to a Recreational Psychoactive Drug in Western Countries.

Authors:  Eduardo Cinosi; Giovanni Martinotti; Pierluigi Simonato; Darshan Singh; Zsolt Demetrovics; Andres Roman-Urrestarazu; Francesco Saverio Bersani; Balasingam Vicknasingam; Giulia Piazzon; Jih-Heng Li; Wen-Jing Yu; Máté Kapitány-Fövény; Judit Farkas; Massimo Di Giannantonio; Ornella Corazza
Journal:  Biomed Res Int       Date:  2015-11-10       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.